Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries

FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL

(2017) R. Gressin et al.   HEMATOLOGICAL ONCOLOGY

A log-rank-type test to compare net survival distributions

(2016) Nathalie Grafféo et al.   BIOMETRICS

Mantle Cell Lymphoma

(2016) Chan Yoon Cheah et al.   JOURNAL OF CLINICAL ONCOLOGY

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

(2016) Olivier Hermine et al.   LANCET

Factors influencing inclusion in digestive cancer clinical trials: A population-based study

(2015) Mathilde Frérot et al.   DIGESTIVE AND LIVER DISEASE

Mantle cell lymphoma epidemiology: a population-based study in France

(2014) Christophe Leux et al.   ANNALS OF HEMATOLOGY

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) M. Dreyling et al.   ANNALS OF ONCOLOGY

Exclusion of Older Patients From Ongoing Clinical Trials for Hematological Malignancies: An Evaluation of the National Institutes of Health Clinical Trial Registry

(2014) M. E. Hamaker et al.   ONCOLOGIST

Are ongoing trials on hematologic malignancies still excluding older subjects?

(2013) A. Cherubini et al.   HAEMATOLOGICA

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte

(2012) R. Delarue et al.   BLOOD

On Estimation in Relative Survival

(2011) Maja Pohar Perme et al.   BIOMETRICS

Differences Between Clinical Trial Participants and Patients in a Population-Based Registry

(2011) Paul Kalata et al.   DISEASES OF THE COLON & RECTUM

Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry

(2011) Anna Abrahamsson et al.   LEUKEMIA & LYMPHOMA

Are patients with Hodgkin lymphoma and high-grade non-Hodgkin lymphoma in clinical therapy optimization protocols representative of these groups of patients in Germany?

(2010) C. Terschuren et al.   ANNALS OF ONCOLOGY

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group

(2010) R. Gressin et al.   HAEMATOLOGICA

Evaluation of factors associated with recruitment in hematological clinical trials: a retrospective cohort study

(2010) Julie Lemieux et al.   Hematology

Current treatment standards and emerging strategies in mantle cell lymphoma

(2009) M. Dreyling et al.   Hematology-American Society of Hematology Education Program

Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004

(2008) Yuhong Zhou et al.   CANCER

Comparison of cancer registry and clinical data as predictors for breast cancer survival

(2008) Johanna Seppänen et al.   CANCER CAUSES & CONTROL